4ZPZ image
Deposition Date 2015-05-08
Release Date 2015-06-10
Last Version Date 2024-11-13
Entry Detail
PDB ID:
4ZPZ
Title:
Crystal Structure of Semi-synthetic Ubiquitin with Phospho-Ser65 and Ala46Cys
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.54 Å
R-Value Free:
0.17
R-Value Work:
0.13
R-Value Observed:
0.14
Space Group:
P 31
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Polyubiquitin-B
Gene (Uniprot):UBB
Mutations:A46C, Phospho-Ser65
Chain IDs:A, B
Chain Length:76
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
Primary Citation
A Versatile Strategy for the Semisynthetic Production of Ser65 Phosphorylated Ubiquitin and Its Biochemical and Structural Characterisation.
Chembiochem 16 1574 1579 (2015)
PMID: 26010437 DOI: 10.1002/cbic.201500185

Abstact

Ubiquitin phosphorylation is emerging as an important regulatory layer in the ubiquitin system. This is exemplified by the phosphorylation of ubiquitin on Ser65 by the Parkinson's disease-associated kinase PINK1, which mediates the activation of the E3 ligase Parkin. Additional phosphorylation sites on ubiquitin might also have important cellular roles. Here we report a versatile strategy for preparing phosphorylated ubiquitin. We biochemically and structurally characterise semisynthetic phospho-Ser65-ubiquitin. Unexpectedly, we observed disulfide bond formation between ubiquitin molecules, and hence a novel crystal form. The method outlined provides a direct approach to study the combinatorial effects of phosphorylation on ubiquitin function. Our analysis also suggests that disulfide engineering of ubiquitin could be a useful strategy for obtaining alternative crystal forms of ubiquitin species thereby facilitating structural validation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures